Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 2004; Volume 65,Issue 2

MINIREVIEW

  • You have access
    Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
    Roya Zoraghi, Jackie D. Corbin and Sharron H. Francis
    Molecular Pharmacology February 2004, 65 (2) 267-278; DOI: https://doi.org/10.1124/mol.65.2.267

Perspective

  • You have access
    Lessons from the CYP3A4 Promoter
    Erin G. Schuetz
    Molecular Pharmacology February 2004, 65 (2) 279-281; DOI: https://doi.org/10.1124/mol.65.2.279

Articles

  • You have access
    Design of a High-Affinity Competitive Antagonist of the Vanilloid Receptor Selective for the Calcium Entry-Linked Receptor Population
    Attila Tóth, Peter M. Blumberg, Zili Chen and Alan P. Kozikowski
    Molecular Pharmacology February 2004, 65 (2) 282-291; DOI: https://doi.org/10.1124/mol.65.2.282
  • You have access
    A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
    Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans and Wen Xie
    Molecular Pharmacology February 2004, 65 (2) 292-300; DOI: https://doi.org/10.1124/mol.65.2.292
  • You have access
    Multiple Pharmacophores for the Investigation of Human UDP-Glucuronosyltransferase Isoform Substrate Selectivity
    Michael J. Sorich, John O. Miners, Ross A. McKinnon and Paul A. Smith
    Molecular Pharmacology February 2004, 65 (2) 301-308; DOI: https://doi.org/10.1124/mol.65.2.301
  • You have access
    Peroxisome Proliferator-Activated Receptor-γ-Independent Repression of Collagenase Gene Expression by 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Prostaglandin 15-Deoxy-Δ(12,14) J2: A Role for Smad Signaling
    Kimberlee S. Mix, Charles I. Coon, Evan D. Rosen, Nanjoo Suh, Michael B. Sporn and Constance E. Brinckerhoff
    Molecular Pharmacology February 2004, 65 (2) 309-318; DOI: https://doi.org/10.1124/mol.65.2.309
  • You have access
    Nitric Oxide Regulates c-fos Expression in Nucleus Tractus Solitarii Induced by Baroreceptor Activation via cGMP-Dependent Protein Kinase and cAMP Response Element-Binding Protein Phosphorylation
    Samuel H. H. Chan, Kui-Fen Chang, Chen-Chun Ou and Julie Y. H. Chan
    Molecular Pharmacology February 2004, 65 (2) 319-325; DOI: https://doi.org/10.1124/mol.65.2.319
  • You have access
    Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
    Keiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, Takeshi Ozeki, Kazuma Kiyotani, Masaki Fujieda, Hiroshi Yamazaki, Hideo Kunitoh and Tetsuya Kamataki
    Molecular Pharmacology February 2004, 65 (2) 326-334; DOI: https://doi.org/10.1124/mol.65.2.326
  • You have access
    New Molecular Determinants Controlling the Accessibility of Ouabain to Its Binding Site in Human Na,K-ATPase α Isoforms
    Gilles Crambert, Daniele Schaer, Sophie Roy and Käthi Geering
    Molecular Pharmacology February 2004, 65 (2) 335-341; DOI: https://doi.org/10.1124/mol.65.2.335
  • You have access
    Proteasome Inhibitors Induce Inhibitory κB (IκB) Kinase Activation, IκBα Degradation, and Nuclear Factor κB Activation in HT-29 Cells
    Zoltán H. Németh, Hector R. Wong, Kelli Odoms, Edwin A. Deitch, Csaba Szabó, E. Sylvester Vizi and György Haskó
    Molecular Pharmacology February 2004, 65 (2) 342-349; DOI: https://doi.org/10.1124/mol.65.2.342
  • You have access
    Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells
    Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger and Benedikt H. J. Pannen
    Molecular Pharmacology February 2004, 65 (2) 350-361; DOI: https://doi.org/10.1124/mol.65.2.350
  • You have access
    The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties
    Bryan N. Becker, Hui-fang Cheng, Timothy G. Hammond and Raymond C. Harris
    Molecular Pharmacology February 2004, 65 (2) 362-369; DOI: https://doi.org/10.1124/mol.65.2.362
  • You have access
    Use-Dependent Inhibition of the N-Methyl-D-aspartate Currents by Felbamate: a Gating Modifier with Selective Binding to the Desensitized Channels
    Chung-Chin Kuo, Bei-Jung Lin, Huai-Ren Chang and Chi-Pan Hsieh
    Molecular Pharmacology February 2004, 65 (2) 370-380; DOI: https://doi.org/10.1124/mol.65.2.370
  • You have access
    Differential Modulation of CaV2.3 Ca2+ Channels by Gαq/11-Coupled Muscarinic Receptors
    R. A. Bannister, K. Melliti and B. A. Adams
    Molecular Pharmacology February 2004, 65 (2) 381-388; DOI: https://doi.org/10.1124/mol.65.2.381
  • You have access
    Bucillamine Induces the Synthesis of Vascular Endothelial Growth Factor Dose-Dependently in Systemic Sclerosis Fibroblasts via Nuclear Factor-κB and Simian Virus 40 Promoter Factor 1 Pathways
    Jörg H. W. Distler, Claudia Hagen, Astrid Hirth, Ulf Müller-Ladner, Hanns M. Lorenz, Angela del Rosso, Beat A. Michel, Renate E. Gay, Ratanavadee Nanagara, Kusuki Nishioka, Marco Matucci-Cerinic, Joachim R. Kalden, Steffen Gay and Oliver Distler
    Molecular Pharmacology February 2004, 65 (2) 389-399; DOI: https://doi.org/10.1124/mol.65.2.389
  • You have access
    Reverse Transcriptase Activity of Hepatitis B Virus (HBV) DNA Polymerase within Core Capsid: Interaction with Deoxynucleoside Triphosphates and Anti-HBV l-Deoxynucleoside Analog Triphosphates
    Wing Lam, Ying Li, Jieh-Yuan Liou, Ginger E. Dutschman and Yung-chi Cheng
    Molecular Pharmacology February 2004, 65 (2) 400-406; DOI: https://doi.org/10.1124/mol.65.2.400
  • You have access
    Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein
    Andreas Papapetropoulos, David Fulton, Michelle I. Lin, Jason Fontana, Timothy J. McCabe, Stefan Zoellner, Guillermo García-Cardeña, Zongmin Zhou, Jean-Phillipe Gratton and William C. Sessa
    Molecular Pharmacology February 2004, 65 (2) 407-415; DOI: https://doi.org/10.1124/mol.65.2.407
  • You have access
    Different Structural Requirements of the Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand Binding and Receptor Activation
    Maria Backlund and Magnus Ingelman-Sundberg
    Molecular Pharmacology February 2004, 65 (2) 416-425; DOI: https://doi.org/10.1124/mol.65.2.416
  • You have access
    Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor
    Gary L. Waldo and T. Kendall Harden
    Molecular Pharmacology February 2004, 65 (2) 426-436; DOI: https://doi.org/10.1124/mol.65.2.426
  • You have access
    Systemic Morphine Administration Suppresses Genes Involved in Antigen Presentation
    Karen Beagles, Anton Wellstein and Barbara Bayer
    Molecular Pharmacology February 2004, 65 (2) 437-442; DOI: https://doi.org/10.1124/mol.65.2.437
  • You have access
    Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
    Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
    Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443
  • You have access
    Pharmacological Properties of α9α10 Nicotinic Acetylcholine Receptors Revealed by Heterologous Expression of Subunit Chimeras
    Elizabeth R. Baker, Ruud Zwart, Emanuele Sher and Neil S. Millar
    Molecular Pharmacology February 2004, 65 (2) 453-460; DOI: https://doi.org/10.1124/mol.65.2.453
  • You have access
    Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
    Aviva Levine-Fridman, Li Chen and Cornelis J. Elferink
    Molecular Pharmacology February 2004, 65 (2) 461-469; DOI: https://doi.org/10.1124/mol.65.2.461
  • You have access
    Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal Myofibroblasts
    Randy C. Mifflin, Jamal I. Saada, John F. Di Mari, John D. Valentich, Patrick A. Adegboyega and Don W. Powell
    Molecular Pharmacology February 2004, 65 (2) 470-478; DOI: https://doi.org/10.1124/mol.65.2.470
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 65 (2)
Molecular Pharmacology
Vol. 65, Issue 2
1 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • MINIREVIEW
  • Perspective
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics